Relay Therapeutics is a clinical-stage precision medicine company that integrates computational and experimental technologies to understand protein motion and transform drug discovery. Their proprietary Dynamo Platform visualizes how proteins move, enabling precise drug design for targets previously considered intractable. The company is advancing a pipeline of medicine candidates for precision oncology and genetic diseases.